NovoCure Limited (NVCR) Net margin 2017–2026
NovoCure Limited (NVCR) net profit margin by fiscal year — reported net income divided by reported revenue.
-20.8%FY2026 · since FY2017: -159.1% → -20.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -20.8% | +7.1 pp |
| FY2025 | -27.9% | +12.7 pp |
| FY2024 | -40.6% | -23.3 pp |
| FY2023 | -17.3% | -6.5 pp |
| FY2022 | -10.8% | -14.8 pp |
| FY2021 | 4.0% | +6.1 pp |
| FY2020 | -2.1% | +23.6 pp |
| FY2019 | -25.6% | +9.2 pp |
| FY2018 | -34.8% | +124.2 pp |
| FY2017 | -159.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice